Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Sonoscape Medical Corp (300633 CH)
Watchlist
39
Analysis
Health Care
•
China
Sonoscape Medical Corp. manufactures medical equipment. The Company develops, produces, and sells ultrasound diagnostic systems, transducers, and other medical equipment products. Sonoscape Medical serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Beijing Wantai Biological Phar
•
14 Oct 2026 18:08
Quiddity Leaderboard CSI Medical Dec26: Expectations Have Changed; US$301mn One-Way
There are three index members failing the liquidity test by narrow margins and they should be monitored until the end of the reference period.
Janaghan Jeyakumar, CFA
Follow
39 Views
Share
bullish
•
Sonoscape Medical Corp
•
12 May 2026 22:33
Primer: Sonoscape Medical Corp (300633 CH) - May 2026
Sonoscape is a prominent Chinese medical device manufacturer specializing in ultrasound and endoscopy systems, capitalizing on domestic...
αSK Primers
117 Views
Share
bearish
•
WuXi AppTec
•
28 Aug 2026 13:50
Quiddity Leaderboard CSI Medical Dec26: US$408mn One-Way Flows; 5 ADDs/DELs Expected
Most of the expected ADDs/DELs could have more than 1x ADV to trade during the December 2026 index rebal event. Although the reference period is...
Janaghan Jeyakumar, CFA
Follow
141 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Mar 2023 08:55
China's 2023 Government Work Report in 14th NPC - The Highlights and the Outlook
We analyzed our interpretation on China's 2023 Government Work Report in 14th NPC, including GDP growth, CPI, fiscal/monetary policy, valuation...
Xinyao (Criss) Wang
Follow
570 Views
Share
bullish
•
Thematic (Sector/Industry)
•
16 Jan 2023 08:55
Identify New Directions of China Healthcare in 2023 – Major Changes In Highest Level Policy Document
China issued the Outline of the Strategic Plan for Expanding Domestic Demand (2022-2035), where some statements have changed, leading to the change...
Xinyao (Criss) Wang
Follow
606 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x